Total-body irradiation in advanced lymphosarcoma.

Area of Science:

• Oncology
• Hematology
• Radiation Oncology

Background:

• Non-Hodgkin's lymphoma is a significant hematologic malignancy.
• Advanced stages (III and IV) present treatment challenges.
• Previous treatments include radiotherapy and chemotherapy.

Purpose of the Study:

• To evaluate the efficacy and toxicity of total-body irradiation (TBI) in advanced non-Hodgkin's lymphoma.
• To identify patient subgroups that benefit most from TBI.

Main Methods:

• Thirty patients with stage III and IV non-Hodgkin's lymphoma were enrolled.
• Treatment involved total-body irradiation (TBI).
• Eleven patients had prior radiotherapy or chemotherapy.

Main Results:

• Complete remission was achieved in 14 out of 30 patients.
• Toxicity was primarily limited to hematological depression.
• Non-leukaemic patients with no prior treatment had the highest remission rate (10/13).

Conclusions:

• Total-body irradiation (TBI) is a beneficial treatment for advanced non-Hodgkin's lymphoma, particularly in non-leukaemic patients.
• TBI demonstrates a favorable risk-benefit profile in this patient group.
• Further investigation into TBI for specific lymphoma subtypes is warranted.